First Moscow State Medical University is the oldest medical university in Russia, located in Moscow. The university was founded in 1758 as medical faculty of Imperial Moscow University as the first medical school in Russia. The institution separated from the Moscow State University and became independent in 1930.

During the past decade, I.M. Sechenov First Moscow State Medical University conducted 124 clinical trials. In the 10-year time frame, 124 clinical trials started and 39 clinical trials were completed, i.e. on average, 31.5% percent of trials that started reached the finish line to date. In the past 5 years, 70 clinical trials started and 33 clinical trials were completed. i.e. 47.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "I.M. Sechenov First Moscow State Medical University" #1 sponsor was "I.M. Sechenov First Moscow State Medical University" with 36 trials, followed by "Hoffmann-La Roche" with 10 trials sponsored, "Eli Lilly and Company" with 9 trials sponsored, "Boehringer Ingelheim" with 8 trials sponsored and "Biocad" with 8 trials sponsored. Other sponsors include 71 different institutions and companies that sponsored additional 51 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "I.M. Sechenov First Moscow State Medical University" #1 collaborator was "I.M. Sechenov First Moscow State Medical University" with 3 trials as a collaborator, "Atlant Clinical Ltd." with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Medivation, Inc." with 2 trials as a collaborator and "OCT Clinical Trials" with 2 trials as a collaborator. Other collaborators include 22 different institutions and companies that were collaborators in the rest 30 trials.

According to Clinical.Site data, the most researched conditions in "I.M. Sechenov First Moscow State Medical University" are "Acromegaly" (6 trials), "COVID-19" (5 trials), "Prostate Cancer" (5 trials), "Rheumatoid Arthritis" (5 trials) and "Juvenile Idiopathic Arthritis" (4 trials). Many other conditions were trialed in "I.M. Sechenov First Moscow State Medical University" in a lesser frequency.

Most popular intervention types in "I.M. Sechenov First Moscow State Medical University" are "Drug" (93 trials), "Procedure" (19 trials), "Other" (14 trials), "Biological" (12 trials) and "Device" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (43 trials), "Baricitinib" (4 trials), "Pembrolizumab" (4 trials), "placebo" (4 trials) and "Carboplatin" (3 trials). Other intervention names were less common.

The vast majority of trials in "I.M. Sechenov First Moscow State Medical University" are 123 trials for "All" genders, 17 trials for "Male" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "I.M. Sechenov First Moscow State Medical University". undefined are not yet recruiting, 29 are recruiting, 17 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 79 completed trials in I.M. Sechenov First Moscow State Medical University, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in I.M. Sechenov First Moscow State Medical University, 12 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 56 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 24 trials that are defined as “Not Applicable".

I.M. Sechenov First Moscow State Medical University has several departments that took part in Clinical trials: "Institute of Dentistry of Sechenov University" - 3 trials